Sat.Aug 01, 2020 - Fri.Aug 07, 2020

article thumbnail

Researchers says hydroxychloroquine could still prevent COVID-19

Pharma Times

Scientists from the University of Oxford say the drug is being ‘discarded prematurely’

170
170
article thumbnail

Health Experts to F.D.A.: Make Your Vaccine Deliberations Public

NY Times

A letter signed by nearly 400 health experts asked the agency to use its vaccine advisory panel when reviewing data on coronavirus trials.

Vaccines 123
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How does HTA for orphan drugs differ across Europe?

pharmaphorum

New research looks at the factors that speed up and slow down HTA appraisals for rare disease medicines across Europe. Rare diseases drugs have always faced challenges when it comes to HTA approvals, even as governments bring in more regulatory policies that make their path through assessment easier. Several factors make it difficult for HTA bodies often to assess orphan drugs, including a lack of robust trial data due to difficulties in finding patients, the absence of randomised controlled tri

Labelling 122
article thumbnail

CSafe, Cloudleaf partner on cold-chain tracking tech

Outsourcing Pharma

The firms are working to create a platform that gives the ability to monitor temperature-sensitive treatments, vaccines and other products.

Vaccines 119
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

UK increases COVID-19 vaccine manufacturing capacity

Pharma Times

New deal with Wockhardt boosts capacity at the crucial 'fill and finish' stage

Vaccines 164

More Trending

article thumbnail

Pfizer signs deal with Gilead to manufacture COVID-19 antiviral remdesivir

pharmaphorum

Pfizer has signed a multi-year agreement with Gilead to manufacture and supply the COVID-19 antiviral remdesivir, which is also being tested in combination with other drugs in an effort to fight the pandemic. Under the terms of the agreement Pfizer will become one of several external partners who manufacture the investigational treatment for the disease.

article thumbnail

Research partnership delves into opioid alternatives

Outsourcing Pharma

Neurasic Therapeutics is borne from a collaborative effort intended to advance development of opioid-alternative pain relief.

101
101
article thumbnail

Pharma’s reputation has climbed during COVID-19 pandemic, study finds

Pharma Times

Roche, AstraZeneca, Novo Nordisk and Sanofi all climbed index rankings

142
142
article thumbnail

6 Key Takeaways from HBA’s “Virtual Best Practices: Clarity, Collaboration and Connecting”

Pharma Marketing Network

Recently, the Healthcare Businesswomen’s Association (HBA) held a webinar entitled, Virtual Best Practices: Clarity, Collaboration and Connecting , which dove into the topic of “Zoom fatigue,” a new, commonly used term defined by the draining feeling you experience after a day of long, unnecessary meetings. We are all facing new challenges in the rapidly changing work environment.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Fearing Brexit chaos, UK asks pharma to build six-week drug stockpile

pharmaphorum

The UK government has asked pharma companies to build a six-week stockpile of drugs and find alternative shipping routes to the congested Dover-Calais crossing as the country heads for Brexit at the end of the year. In a letter , Steve Oldfield, chief commercial officer at the Department of Health and Social Care, said the government is focused on preventing potential disruption to any categories of medical supplies.

111
111
article thumbnail

Senate bill proposes study of the US pharma supply chain

Outsourcing Pharma

The bipartisan bill calls for an assessment of the countryâs pharma supply chain, including potential vulnerabilities and impact of foreign manufacturing.

98
article thumbnail

Janssen’s depression nasal spray Spravato bags new FDA approval

Pharma Times

Drug approved to treat major depressive disorder with acute suicidal ideation or behaviour

142
142
article thumbnail

Using Telemedicine to Treat Opioid Addiction

NY Times

Getting medication long meant seeing a licensed provider. Now a strategy for evading Covid-19 makes treatment available via the web.

76
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Redx shares soar after IPF drug licence deal with AstraZeneca

pharmaphorum

Shares in Redx Pharma were soaring this morning after it licensed its preclinical fibrotic disease drug RXC006 to AstraZeneca. The company’s shares were valued as high as 95p on the London Stock Exchange following the announcement, the highest they had been since 2015. AstraZeneca has bought an exclusive global licence to develop and market RXC006, a porcupine inhibitor for fibrotic diseases including idiopathic pulmonary fibrosis (IPF).

106
106
article thumbnail

ACD/Labs: tech can overcome supply chain challenges

Outsourcing Pharma

A leader from the scientific software provider discusses the most challenging obstacles in the pharma supply chain, and solutions that can conquer them.

69
article thumbnail

Genmab/Janssen’s Darzalex combo hits the mark in phase 3 study

Pharma Times

Subcutaneous formulation of Darzalex in combination with pomalidomide and dexamethasone meets primary endpoint

137
137
article thumbnail

Finding and Evaluating Market Entry Opportunities for a Better ROI

Drug Patent Watch

I’ll be giving a talk on Finding and Evaluating Market Entry Opportunities for a Better ROI at the upcoming 13th Portfolio Management & Pipeline Optimization for Generics from September 30th…. The post Finding and Evaluating Market Entry Opportunities for a Better ROI appeared first on DrugPatentWatch - Make Better Decisions.

52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Coronavirus pharma news roundup – 07/08/20

pharmaphorum

Pharma’s reputation has soared due to the COVID-19 pandemic – but coronavirus is starting to bite companies’ sales. Find out more in our roundup of the biggest R&D, market access and digital stories from the past week. The perception of pharma and medical companies has surged upward since the start of the COVID-19 pandemic, but they still lie mostly outside the top-rated firms in the FutureBrand Index.

article thumbnail

This week's FDA COVID-19 news

Outsourcing Pharma

The agency continues to provide resources for the life-sciences industry, approve tests, and take action against companies offering false treatments.

60
article thumbnail

AstraZeneca forges licensing agreement with Redx Pharma

Pharma Times

AZ will pay $17m in early milestone payments for the UK biotech’s fibrotic asset

137
137
article thumbnail

Patient Assistance Programs–Weathering COVID-19 and the Unknown

Drug Channels

Today’s guest post comes from Rob Brown, VP/GM of RxCrossroads by McKesson Program Pharmacy. Rob reviews how COVID-19 is changing patient access and adherence to specialty therapies. He then describes specific RxCrossroads’ program changes that are helping patients and providers remain on therapy and navigate this challenging environment. To learn more, visit www.McKesson.com/RxCrossroads.

40
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Sanofi faces possible manslaughter charges in epilepsy drug probe

pharmaphorum

Sanofi has been placed under formal investigation in France for possible charges including manslaughter relating to the epilepsy drug Depakine, following the deaths of four babies whose mothers took the drug. Depakine was found to carry a high risk of birth defects if taken by pregnant women. Sanofi , which denies wrongdoing and says it warned of the risks long ago, is already being prosecuted in France following allegations it provided misleading information about the drug.

article thumbnail

IBM: speed is vital with COVID-era trials

Outsourcing Pharma

A leader from IBM Watson Health talks about how its advanced EDC solution is geared toward helping studies save precious time and conserve costs.

59
article thumbnail

Oxford Biomedica and Beam Therapeutics sign CAR-T deal

Pharma Times

Agreement will utilise Oxford Biomedica's LentiVector platform

137
137
article thumbnail

Episode 528: What dose of inhaled tranexamic acid is used for nonmassive hemoptysis?

Pharmacy Joe

In this episode, I’ll discuss the dose of inhaled tranexamic acid used for nonmassive hemoptysis. Episode 528: What dose of inhaled tranexamic acid is used for nonmassive hemoptysis? Subscribe on iTunes , Android , or Stitcher Tranexamic acid (TA) is an antifibrinolytic medication. It forms a reversible complex that displaces plasminogen from fibrin resulting in inhibition of fibrinolysis.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.